Form 4: Astera Labs Director Michael Hurlston Sells Shares Under 10b5-1 Trading Plan

Director Michael Hurlston of Astera Labs sold shares of common stock on February 18, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Michael Hurlston, a director of Astera Labs, Inc., sold shares of the company's common stock on February 18, 2025.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 28, 2024.
• A total of 2,499 shares were sold in multiple transactions at varying prices.
• The prices ranged from $88.23 to $94.48 per share.
• Following the reported transactions, Hurlston beneficially owns 91,794 shares of Astera Labs common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating insider trading activity. The sentiment is neutral as it simply reports transactions under a pre-existing plan.

Industry Context

Insider sales are a common occurrence, and sales under 10b5-1 plans are generally viewed as less impactful since they are pre-scheduled. However, investors often monitor insider activity for signals about a company's prospects.

Stakeholder Impact

• The stock sale by a director could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates

Keywords

Astera Labs, ALAB, Michael Hurlston, Form 4, insider trading, Rule 10b5-1, stock sale, director